Goods & Services

Dietary foodstuffs for medical use; dietetic foodstuffs for veterinary use; food supplements. Advertising; commercial business management; commercial administration; dissemination of advertising material (leaflets, prospectuses, printed matter, samples); presentation of goods on all communication media for retailing; document reproduction; computerized file management service; website traffic optimization; organization of exhibitions for commercial or advertising purposes; online advertising on a computer network; rental of advertising time on all communication media; publication of advertising texts; rental of advertising space; dissemination of advertisements; advice regarding communication (advertising); public relations; advice regarding communication (public relations).

Abstract

A composition for use in the treatment and/or prevention of adverse side effects induced by an anti-cancer compound, said composition comprising an aqueous liquid extract, the aqueous liquid extract comprising Phycocyanin. The present invention also relates to the use of this aqueous liquid extract comprising Phycocyanin and optionally Spirulina polysaccharides, for the treatment and/or prevention of adverse side effects induced by an anti-cancer compound. A composition for use in the treatment and/or prevention of adverse side effects induced by an anti-cancer compound, said composition comprising an aqueous liquid extract, the aqueous liquid extract comprising Phycocyanin. The present invention also relates to the use of this aqueous liquid extract comprising Phycocyanin and optionally Spirulina polysaccharides, for the treatment and/or prevention of adverse side effects induced by an anti-cancer compound. Indeed, Phycocyanin, thanks to its antioxidant effects, can reduce the undesirable side effects induced by an anti-cancer compound.

IPC Classes  ?

• A61K 35/748 - Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
• A61K 38/16 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof
• A61P 25/02 - Drugs for disorders of the nervous system for peripheral neuropathies

Goods & Services

Laundry preparations; polishing preparations; degreasing preparations; abrasive preparations; soaps; perfumes; essential oils; cosmetics; lotions for hair; dentifrices; depilatories; make-up removing products; lipstick; beauty masks; shaving products; preservatives for leather (polishes); creams for leather. Pharmaceutical products; veterinary products; sanitary products for medicine; disinfectant soaps; medicinal soaps; medicated shampoos; medicated dentifrices; dietetic foods for medical use; dietetic foodstuffs for veterinary use; food for babies; food supplements; articles for dressings; teeth filling materials; dental impression materials; antibacterial products for washing hands; bath preparations for medical use; sanitary panties; sanitary towels; chemical preparations for medical use; chemical preparations for pharmaceutical use; medicinal herbs; medicinal herbal teas; alloys of precious metals for dental use. Advertising; commercial business management; commercial administration; office functions; dissemination of advertising material (leaflets, prospectuses, printed matter, samples); newspaper subscription services (for third parties); arranging subscriptions to telecommunication services for third parties; business management and organization consultancy; accounting; photocopying services; employment agency services; business management for freelance service providers; computerized file management service; traffic optimization for websites; organization of exhibitions for commercial or advertising purposes; online advertising on a computer network; rental of advertising time on all communication media; publication of advertising texts; rental of advertising space; dissemination of advertisements; advice regarding communication (advertising); public relations; advice regarding communication (public relations); company audits (commercial analyses); commercial intermediation services.

Abstract

A composition for use in the treatment and/or prevention of adverse side effects induced by an anti-cancer compound, said composition comprising an aqueous liquid extract, the aqueous liquid extract comprising Phycocyanin. The present invention also relates to the use of this aqueous liquid extract comprising Phycocyanin and optionally Spirulina polysaccharides, for the treatment and/or prevention of adverse side effects induced by an anti-cancer compound. A composition for use in the treatment and/or prevention of adverse side effects induced by an anti-cancer compound, said composition comprising an aqueous liquid extract, the aqueous liquid extract comprising Phycocyanin. The present invention also relates to the use of this aqueous liquid extract comprising Phycocyanin and optionally Spirulina polysaccharides, for the treatment and/or prevention of adverse side effects induced by an anti-cancer compound. Indeed, Phycocyanin, thanks to its antioxidant effects, can reduce the undesirable side effects induced by an anti-cancer compound.

IPC Classes  ?

• A61K 35/748 - Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
• A61K 38/16 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof
• A61P 25/02 - Drugs for disorders of the nervous system for peripheral neuropathies

Abstract

Composition for use in a method of protecting mammalian subjects against atherosclerosis development, in particular against atheroma formation or in atheroma reduction, by oral administration of an aqueous liquid extract of spirulina including phycocyanin. Said composition can be used in a method of protecting genetically hypercholestolemic mammalian subjects against atherosclerosis development. Moreover, said composition can be used especially for protecting offspring mammalian subjects against atherosclerosis development, by oral administration to mothers of the offspring subjects of said composition at least during a part of the gestation period of the offspring mother or at least during part of the gestation period and of the lactation period.

IPC Classes  ?

• A61P 9/10 - Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
• A61K 36/02 - Algae

Abstract

Composition for use in treating and/or preventing the undesirable side effects caused by an anti-cancer compound, said composition comprising an aqueous liquid extract, the aqueous liquid extract comprising phycocyanin. The present invention also relates to the use of said aqueous liquid extract comprising phycocyanin, and optionally spirulina polysaccharides, for treating and/or preventing the undesirable side effects caused by an anti-cancer compound. Indeed, phycocyanin can be used, mainly due to its antioxidant effects, to reduce the undesirable side effects caused by an anti-cancer compound.

IPC Classes  ?

• A61K 35/748 - Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
• A61K 38/16 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof
• A61P 25/02 - Drugs for disorders of the nervous system for peripheral neuropathies
• A61P 39/00 - General protective or antinoxious agents

Abstract

Composition for use in treating and/or preventing the undesirable side effects caused by an anti-cancer compound, said composition comprising an aqueous liquid extract, the aqueous liquid extract comprising phycocyanin. The present invention also relates to the use of said aqueous liquid extract comprising phycocyanin, and optionally spirulina polysaccharides, for treating and/or preventing the undesirable side effects caused by an anti-cancer compound. Indeed, phycocyanin can be used, mainly due to its antioxidant effects, to reduce the undesirable side effects caused by an anti-cancer compound.

IPC Classes  ?

• A61K 38/16 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof
• A61K 35/748 - Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
• A61P 1/16 - Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
• A61P 9/00 - Drugs for disorders of the cardiovascular system
• A61P 13/12 - Drugs for disorders of the urinary system of the kidneys
• A61P 25/02 - Drugs for disorders of the nervous system for peripheral neuropathies
• A61P 39/06 - Free radical scavengers or antioxidants

Abstract

Composition comprising an aqueous liquid extract of phycobiliproteins, containing phycocyanin, which is obtained from cyanobacteria or micro-algae and which has not been subjected to any drying step, said composition being used to prevent or treat lipido-carbohydrate metabolism disorders in humans or mammals. In particular, the composition can be used to prevent or treat non-alcoholic hepatic steatosis or steatohepatitis.

IPC Classes  ?

• A61K 35/748 - Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
• C07K 14/195 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria
• A61P 1/16 - Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
• A61P 3/00 - Drugs for disorders of the metabolism

Abstract

A method for preparing a liquid extract rich in phycocyanin from cyanobacteria or microalgae containing phycocyanin in solution, comprising a step of carrying out the cellular lysis of an aqueous suspension of said fresh cyanobacteria or microalgae, a step of macerating the lysate obtained, for several hours in a solution of divalent cations, while releasing the water-soluble molecules in the extracellular space, and one or more steps of clarifying and concentrating the suspension in order to isolate the water-soluble molecules, among them phycocyanin. This method is performed at a pH between 5 and 8.5, at room temperature, without drying. Of the phycocyanin of the original biomass, 99% is recovered. The aqueous extract obtained is stable over time and comprises a content of phycocyanin in non-denatured solution that may be greater than 0.5 g/L, having an antioxidant activity demonstrated in vivo.

IPC Classes  ?

• C07K 14/405 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from algae
• C07K 14/795 - Porphyrin- or corrin-ring-containing peptides
• C07K 1/14 - ExtractionSeparationPurification

Abstract

The invention relates to a method for producing membrane polysaccharides from an organism selected from micro-organisms, unicellular organisms and filamentous fungi, said method comprising at least one step of extracting said membrane polysaccharides as well as a smaller-scale extraction of the soluble proteins, by mechanical treatment of said organism in a ball mill or by physical treatment of said organism by means of ultrasounds.

IPC Classes  ?

• A01G 33/00 - Cultivation of seaweed
• C12N 1/12 - Unicellular algaeCulture media therefor
• A61K 8/73 - Polysaccharides
• A61K 47/36 - PolysaccharidesDerivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
• A61K 31/715 - Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkagesDerivatives thereof, e.g. ethers, esters

Abstract

The invention relates to a viscoelastic material characterised in that it is produced by recovery of the hydrophobic phase obtained by a method of hydrothermal liquefaction from a biomass comprising at least one microalga and comprising at least 40 wt.% of water in relation to the total weight of the biomass, said hydrophobic phase comprising a viscoelastic oil and solid residues, wherein the quantity of solid residues amounts to between 15 wt.% and 30 wt.% of the total weight of the hydrophobic phase.

IPC Classes  ?

• C08H 99/00 - Subject matter not provided for in other groups of this subclass
• C09J 199/00 - Adhesives based on natural macromolecular compounds or on derivatives thereof, not provided for in groups or
• C08L 99/00 - Compositions of natural macromolecular compounds or of derivatives thereof not provided for in groups or
• C04B 26/00 - Compositions of mortars, concrete or artificial stone, containing only organic binders
• C04B 26/28 - Polysaccharides or derivatives thereof
• C04B 18/24 - Vegetable refuse, e.g. rice husks, maize-ear refuseCellulosic materials, e.g. paper
• E01C 7/00 - Coherent pavings made in situ
• C08H 8/00 - Macromolecular compounds derived from lignocellulosic materials
• C09J 191/00 - Adhesives based on oils, fats or waxesAdhesives based on derivatives thereof
• C08L 91/00 - Compositions of oils, fats or waxesCompositions of derivatives thereof